Verfügbarkeit: Apomorphine in Parkinson's disease

Apomorphine in Parkinson's disease:

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Hagell, Peter (VerfasserIn), Odin, Per (VerfasserIn)
Format:	Buch
Sprache:	English
Veröffentlicht:	Bremen ; London ; Boston UNI-MED Verlag AG [2014]
Ausgabe:	3rd edition
Schriftenreihe:	UNI-MED science
Schlagworte:	Apomorphin Parkinson-Krankheit
Online-Zugang:	Zusätzliche Angaben Inhaltsverzeichnis Inhaltsverzeichnis
Beschreibung:	Literaturangaben
Beschreibung:	95 Seiten Illustrationen 25 cm
ISBN:	9783837414523 9781848152151

Internformat

MARC


LEADER	00000nam a2200000 c 4500
001	BV044209505
003	DE-604
005	20200610
007	t
008	170303s2014 a\|\|\| \|\|\|\| 00\|\|\| eng d
015			\|a 14,A42 \|2 dnb
016	7		\|a 1056885246 \|2 DE-101
020			\|a 9783837414523 \|c Pp. : EUR 39.80 \|9 978-3-8374-1452-3
020			\|a 9781848152151 \|c Pp. \|9 978-1-84815-215-1
035			\|a (OCoLC)893437605
035			\|a (DE-599)DNB1056885246
040			\|a DE-604 \|b ger \|e rda
041	0		\|a eng
049			\|a DE-355
082	0		\|a 616.833061 \|2 22/ger
084			\|a YG 5515 \|0 (DE-625)153506:12921 \|2 rvk
084			\|a 610 \|2 sdnb
100	1		\|a Hagell, Peter \|e Verfasser \|0 (DE-588)1208218360 \|4 aut
245	1	0	\|a Apomorphine in Parkinson's disease \|c Peter Hagell, Per Odin
250			\|a 3rd edition
264		1	\|a Bremen ; London ; Boston \|b UNI-MED Verlag AG \|c [2014]
300			\|a 95 Seiten \|b Illustrationen \|c 25 cm
336			\|b txt \|2 rdacontent
337			\|b n \|2 rdamedia
338			\|b nc \|2 rdacarrier
490	0		\|a UNI-MED science
500			\|a Literaturangaben
650	0	7	\|a Apomorphin \|0 (DE-588)4282713-9 \|2 gnd \|9 rswk-swf
650	0	7	\|a Parkinson-Krankheit \|0 (DE-588)4044683-9 \|2 gnd \|9 rswk-swf
689	0	0	\|a Parkinson-Krankheit \|0 (DE-588)4044683-9 \|D s
689	0	1	\|a Apomorphin \|0 (DE-588)4282713-9 \|D s
689	0		\|5 DE-604
700	1		\|a Odin, Per \|e Verfasser \|0 (DE-588)1013654072 \|4 aut
856	4		\|u http://digitool.hbz-nrw.de:1801/webclient/DeliveryManager?pid=6068130&custom_att_2=simple_viewer \|y Apomorphine in Parkinson's disease \|3 Zusätzliche Angaben
856	4	2	\|m B:DE-101 \|q application/pdf \|u http://digitool.hbz-nrw.de:1801/webclient/DeliveryManager?pid=6068129&custom_att_2=simple_viewer \|3 Inhaltsverzeichnis
856	4	2	\|m DNB Datenaustausch \|q application/pdf \|u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=029615824&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA \|3 Inhaltsverzeichnis
999			\|a oai:aleph.bib-bvb.de:BVB01-029615824

Datensatz im Suchindex

_version_	1804177350383894528
adam_text	CONTENTS 9 CONTENTS M A BRIEF HISTORY OF APOMORPHINE 12 CLINICAL PHARMACOLOGY OF APOMORPHINE 16 M NEUROPROTECTIVE EFFECTS OF APOMORPHINE IN PARKINSON S DISEASE 20 \| DIAGNOSTIC USE OF APOMORPHINE IN PARKINSON S DISEASE 24 4.1. INTRODUCTION 24 4.2. TEST PERFORMANCE 24 4.3. DIAGNOSTIC VALUE 26 4.4. CHALLENGE TESTS: APOMORPHINE VS. LEVODOPA 28 4.5. SUMMARY 29 M APOMORPHINE IN THE TREATMENT OF PARKINSON S DISEASE 32 ^ INTERMITTENT SUBCUTANEOUS APOMORPHINE INJECTION 34 6.1. INDICATIONS FOR APOMORPHINE PEN THERAPY - A SUITABLE PATIENT 34 6.2. THE APOMORPHINE TEST 35 6.3. USE OF DOMPERIDONE 36 6.4. STARTING APOMORPHINE THERAPY 36 6.5. TYPICAL APOMORPHINE DOSES 37 6.6. EFFECTS OF APOMORPHINE THERAPY 37 6.7. SIDE EFFECTS 40 6.8. DRUG INTERACTIONS 40 6.9. ALTERNATIVE MODES OF ADMINISTRATION 40 6.10. SUMMARY 41 ^ CONTINUOUS DOPAMINERGIC STIMULATION 44 11 CONTINUOUS SUBCUTANEOUS APOMORPHINE INFUSION 48 8.1. CLINICAL EXPERIENCE FROM CONTINUOUS S.C. APOMORPHINE INFUSION 49 8.2. DYSKINESIAS AND CONTINUOUS S.C. APOMORPHINE INFUSION 50 8.3. CONTINUOUS S.C. APOMORPHINE INFUSION AND FUNCTIONAL NEUROSURGERY 52 8.4. CONTINUOUS S.C. APOMORPHINE INFUSION VERSUS LEVODOPA/CARBIDOPA INTESTINAL GEL INFUSION. 54 8.5. CONTINUOUS S.C. APOMORPHINE INFUSION, LEVODOPA/ CARBIDOPA INTESTINAL GEL INFUSION AND STN-DBS: THE CHOICE OF ADVANCED PD THERAPY 54 8.6. ALTERNATIVE ROUTES OF CONTINUOUS APOMORPHINE ADMINISTRATION 54 8.7. SUMMARY 57 F SIDE EFFECTS OF APOMORPHINE THERAPY 60 9.1. SUBCUTANEOUS NODULES 60 9.2. NEUROPSYCHIATRIC EVENTS 61 9.3. NAUSEA 65 9.4. ORTHOSTATIC HYPOTENSION 65 HTTP://D-NB.INFO/1056885246 10 CONTENTS 9.5. HEMOLYTIC ANEMIA 65 9.6. SEDATION, SOMNOLENCE AND SLEEP ATTACKS 65 9.7. IMPULSE CONTROL DISORDERS AND HYPERSEXUALITY 66 9.8. OTHER SIDE EFFECTS 66 9.9. INJECTABLE APOMORPHINE SAFETY DATABASE 66 9.10. PREGNANCY AND LACTATION 66 9.11. OVERDOSE 67 9.12. TECHNICAL DIFFICULTIES 67 9.13. SUMMARY 67 * HEALTH ECONOMY AND PATIENT-REPORTED HEALTH OUTCOMES 70 10.1. HEALTH ECONOMY 70 10.2. PATIENT-REPORTED HEALTH OUTCOMES 71 * PRACTICAL ASPECTS OF APOMORPHINE THERAPY 74 11.1. PRE-TREATMENT CONSIDERATIONS 74 11.2. INTERMITTENT S.C. APOMORPHINE INJECTIONS 74 11.3. CONTINUOUS S.C. APOMORPHINE INFUSION 75 11.4. EDUCATION AND SUPPORT 76 11.5. FOLLOW-UP 79 WM CONCLUDING REMARKS 82 REFERENCES 84 INDEX 94
any_adam_object	1
author	Hagell, Peter Odin, Per
author_GND	(DE-588)1208218360 (DE-588)1013654072
author_facet	Hagell, Peter Odin, Per
author_role	aut aut
author_sort	Hagell, Peter
author_variant	p h ph p o po
building	Verbundindex
bvnumber	BV044209505
classification_rvk	YG 5515
ctrlnum	(OCoLC)893437605 (DE-599)DNB1056885246
dewey-full	616.833061
dewey-hundreds	600 - Technology (Applied sciences)
dewey-ones	616 - Diseases
dewey-raw	616.833061
dewey-search	616.833061
dewey-sort	3616.833061
dewey-tens	610 - Medicine and health
discipline	Medizin
edition	3rd edition
format	Book
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02001nam a2200469 c 4500</leader><controlfield tag="001">BV044209505</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20200610 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">170303s2014 a\|\|\| \|\|\|\| 00\|\|\| eng d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">14,A42</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">1056885246</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783837414523</subfield><subfield code="c">Pp. : EUR 39.80</subfield><subfield code="9">978-3-8374-1452-3</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781848152151</subfield><subfield code="c">Pp.</subfield><subfield code="9">978-1-84815-215-1</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)893437605</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DNB1056885246</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.833061</subfield><subfield code="2">22/ger</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YG 5515</subfield><subfield code="0">(DE-625)153506:12921</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">610</subfield><subfield code="2">sdnb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Hagell, Peter</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)1208218360</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Apomorphine in Parkinson's disease</subfield><subfield code="c">Peter Hagell, Per Odin</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">3rd edition</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Bremen ; London ; Boston</subfield><subfield code="b">UNI-MED Verlag AG</subfield><subfield code="c">[2014]</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">95 Seiten</subfield><subfield code="b">Illustrationen</subfield><subfield code="c">25 cm</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">UNI-MED science</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Literaturangaben</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Apomorphin</subfield><subfield code="0">(DE-588)4282713-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Parkinson-Krankheit</subfield><subfield code="0">(DE-588)4044683-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Parkinson-Krankheit</subfield><subfield code="0">(DE-588)4044683-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Apomorphin</subfield><subfield code="0">(DE-588)4282713-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Odin, Per</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)1013654072</subfield><subfield code="4">aut</subfield></datafield><datafield tag="856" ind1="4" ind2=" "><subfield code="u">http://digitool.hbz-nrw.de:1801/webclient/DeliveryManager?pid=6068130&custom_att_2=simple_viewer</subfield><subfield code="y">Apomorphine in Parkinson's disease</subfield><subfield code="3">Zusätzliche Angaben</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">B:DE-101</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://digitool.hbz-nrw.de:1801/webclient/DeliveryManager?pid=6068129&custom_att_2=simple_viewer</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">DNB Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=029615824&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029615824</subfield></datafield></record></collection>
id	DE-604.BV044209505
illustrated	Illustrated
indexdate	2024-07-10T07:46:41Z
institution	BVB
isbn	9783837414523 9781848152151
language	English
oai_aleph_id	oai:aleph.bib-bvb.de:BVB01-029615824
oclc_num	893437605
open_access_boolean
owner	DE-355 DE-BY-UBR
owner_facet	DE-355 DE-BY-UBR
physical	95 Seiten Illustrationen 25 cm
publishDate	2014
publishDateSearch	2014
publishDateSort	2014
publisher	UNI-MED Verlag AG
record_format	marc
series2	UNI-MED science
spelling	Hagell, Peter Verfasser (DE-588)1208218360 aut Apomorphine in Parkinson's disease Peter Hagell, Per Odin 3rd edition Bremen ; London ; Boston UNI-MED Verlag AG [2014] 95 Seiten Illustrationen 25 cm txt rdacontent n rdamedia nc rdacarrier UNI-MED science Literaturangaben Apomorphin (DE-588)4282713-9 gnd rswk-swf Parkinson-Krankheit (DE-588)4044683-9 gnd rswk-swf Parkinson-Krankheit (DE-588)4044683-9 s Apomorphin (DE-588)4282713-9 s DE-604 Odin, Per Verfasser (DE-588)1013654072 aut http://digitool.hbz-nrw.de:1801/webclient/DeliveryManager?pid=6068130&custom_att_2=simple_viewer Apomorphine in Parkinson's disease Zusätzliche Angaben B:DE-101 application/pdf http://digitool.hbz-nrw.de:1801/webclient/DeliveryManager?pid=6068129&custom_att_2=simple_viewer Inhaltsverzeichnis DNB Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=029615824&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis
spellingShingle	Hagell, Peter Odin, Per Apomorphine in Parkinson's disease Apomorphin (DE-588)4282713-9 gnd Parkinson-Krankheit (DE-588)4044683-9 gnd
subject_GND	(DE-588)4282713-9 (DE-588)4044683-9
title	Apomorphine in Parkinson's disease
title_auth	Apomorphine in Parkinson's disease
title_exact_search	Apomorphine in Parkinson's disease
title_full	Apomorphine in Parkinson's disease Peter Hagell, Per Odin
title_fullStr	Apomorphine in Parkinson's disease Peter Hagell, Per Odin
title_full_unstemmed	Apomorphine in Parkinson's disease Peter Hagell, Per Odin
title_short	Apomorphine in Parkinson's disease
title_sort	apomorphine in parkinson s disease
topic	Apomorphin (DE-588)4282713-9 gnd Parkinson-Krankheit (DE-588)4044683-9 gnd
topic_facet	Apomorphin Parkinson-Krankheit
url	http://digitool.hbz-nrw.de:1801/webclient/DeliveryManager?pid=6068130&custom_att_2=simple_viewer http://digitool.hbz-nrw.de:1801/webclient/DeliveryManager?pid=6068129&custom_att_2=simple_viewer http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=029615824&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA
work_keys_str_mv	AT hagellpeter apomorphineinparkinsonsdisease AT odinper apomorphineinparkinsonsdisease

Verfügbarkeit

Es ist kein Print-Exemplar vorhanden.

Fernleihe Bestellen Achtung: Nicht im THWS-Bestand! Inhaltsverzeichnis
Inhaltsverzeichnis

MARC

Datensatz im Suchindex

Es ist kein Print-Exemplar vorhanden.

Ähnliche Einträge